Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57549 | 0.84 | — | — | |
| Anthraquinone SCHEMBL11140999 | 0.82 | CDC25B (0.52) | — | |
| Methane SCHEMBL190374 | 0.82 | — | — | |
| Ammonia Solution, Strong SCHEMBL3496230 | 0.82 | — | — | |
| SCHEMBL2221687 | 0.82 | — | — | |
| Methane SCHEMBL222390 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL1554036 | 0.82 | — | — | |
| Lithium SCHEMBL17474380 | 0.82 | — | — | |
| Quinoline SCHEMBL1647025 | 0.81 | ALDH1A1 (0.59) | HSP90AA1 | |
| Chlorobenzene SCHEMBL11324480 | 0.80 | TSHR (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100055116-A1 | Methods and Compositions for Targeting c-Rel | CORNELL RESEARCH FOUNDATION, INC. | 2010-03-04 | — | — | US | disclosed |
| CN-101460634-A | Methods and compositions for targeting C-REL | CORNELL RES FOUNDATION INC (US) | 2009-06-17 | — | — | CN | disclosed |
| EP-2010225-A2 | METHODS AND COMPOSITIONS FOR TARGETING C-REL | Cornell Research Foundation, Inc. (US) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007120842-A2 | METHODS AND COMPOSITIONS FOR TARGETING C-REL | CORNELL RESEARCH FOUNDATION, INC. (US) | 2007-10-25 | — | — | WO | disclosed |
| US-4267253-A | AND PHOTOGRAPHIC FILMS CONTAINING THEM | POLAROID CORPORATION (US) | 1981-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100055116-A1 | Methods and Compositions for Targeting c-Rel | REL, NFATC1, MYCBP | CYP2A6 4833/4885ALOX12 4052/4885GSTP1 2731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.